With 1.52 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.49 million shares. The 52-week range on RNA shows that it touched its highest point at $56.00 and its lowest point at $21.51 during that stretch. It currently has a 1-year price target of $66.79. Beta for the stock currently stands at 0.95.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of RNA was up-trending over the past week, with a rise of 0.55%, but this was down by -5.11% over a month. Three-month performance surged to 1.11% while six-month performance fell -31.35%. The stock gained 17.71% in the past year, while it has gained 6.53% so far this year. A look at the trailing 12-month EPS for RNA yields -3.01 with Next year EPS estimates of -4.42. For the next quarter, that number is -0.95. This implies an EPS growth rate of -36.98% for this year and -11.64% for next year. EPS is expected to decline by -1.71% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -34.37%.
Float and Shares Shorts:
At present, 120.51 million RNA shares are outstanding with a float of 109.84 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for RNA since 6 analysts follow the stock currently. There are 5 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$2.70057 being high and -$2.9885 being low. For RNA, this leads to a yearly average estimate of -$2.86936.
